Overview

Metabolic Capacity of Israeli Populations

Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The ability to metabolize drugs varies greatly among individuals. Major fraction of this variability lies in genetic polymorphisms of genes encoding for enzymes responsible for both phase I and phase II reactions. The purpose of this study ws to evaluate the phenotypic activity and the frequency of genetic polymorphisms in different phase II and phase I enzymes among various populations residing in Israel.
Phase:
N/A
Details
Lead Sponsor:
Hadassah Medical Organization
Treatments:
Caffeine
Dapsone
Debrisoquin
Mephenytoin